Effect of oral estrogen on substrate utilization in postmenopausal women

Fertil Steril. 2008 Oct;90(4):1275-8. doi: 10.1016/j.fertnstert.2007.07.1317. Epub 2007 Nov 14.

Abstract

We tested the hypothesis that a 2-month intervention with unopposed oral conjugated equine estrogens (0.625 mg/d) would decrease lipid oxidation, as assessed by 24-hour, whole-room, indirect calorimetry in 14 postmenopausal women. Estrogen (E) treatment was associated with declines in both 24-hour and postprandial lipid oxidation and an increase in fat mass (mean [+/-SD] 2-month difference 1.1 +/- 1.0 kg; mean 6-month difference 1.8 +/- 2.2 kg), suggesting that, on an acute basis, oral E may increase adiposity by limiting lipid oxidation.

Publication types

  • Clinical Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Dose-Response Relationship, Drug
  • Estrogens / administration & dosage*
  • Female
  • Hormone Replacement Therapy / methods*
  • Humans
  • Lipid Metabolism / drug effects
  • Lipid Metabolism / physiology*
  • Lipid Peroxidation / drug effects
  • Lipid Peroxidation / physiology*
  • Middle Aged
  • Postmenopause / drug effects
  • Postmenopause / metabolism*

Substances

  • Estrogens